Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000030635
JPRN-UMIN000030635
Completed
未知

Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study) - Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)

Osaka City University0 sites3,000 target enrollmentJanuary 1, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions1. Cardiovascular disease (coronary arterial disease, cerebrovascular disease, peripheral arterial disease) 2. Conditions at high risk of cardiovascular disease (diabetes mellitus, chronic kidney disease including stage 5D) 3. Those who do not have the above diseases

Overview

Phase
未知
Intervention
Not specified
Conditions
1. Cardiovascular disease (coronary arterial disease, cerebrovascular disease, peripheral arterial disease) 2. Conditions at high risk of cardiovascular disease (diabetes mellitus, chronic kidney disease including stage 5D) 3. Those who do not have the above diseases
Sponsor
Osaka City University
Enrollment
3000
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 1, 2018
End Date
June 30, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\. Participants will be opt\-out when the participants and/or their family members do not want to participate in this study upon information disclosure of this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Serum levels of Cholesterol synthesis/absorption markers in subjects of various diseases.ormal subjects, Diabetes, Hyperlipidemia, Essential hypertension, Metabolic syndrome
JPRN-UMIN000004946Department of Metabolic Medicine, Faculty of life sciences, Kumamoto University600
Completed
Phase 4
Therapeutic effects of cholesterol absorption inhibitor on renal function in patients with chronic kidney diseaseChronic kidney disease Hypercholesterolemia
JPRN-UMIN000002528Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine50
Completed
Not Applicable
Beneficial effects of cholesterol absorption inhibitor,ezetimibe on impaired endothelial function in patients with metabolic syndrome.Metabolic syndrome
JPRN-UMIN000001305Tohoku University Graduate School of Medicine EZET-trial group60
Not yet recruiting
Not Applicable
Cholesterol Absorption Inhibition Study in humans after single intake of cholesterol lowering margarine, Unilever Study 09030-V, Study name: CASTEmild hypercholesterolemiaslightly elevated cholesterol10013317
NL-OMON34622nilever18
Completed
Phase 4
Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSoundpatients aged 30-85 years who were undergoing percutaneous coronary intervention (PCI, elective or emergency) with &gt=1 significant stenosis &gt=75% and &gt=1 untouched nonculprit lesion of &lt=50% stenosis that could be imaged by intravascular ultrasound, and either LDL-C &gt=100 mg/dl.
JPRN-UMIN000002959Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University300